Hemodynamics is a systematic function of cardiovascular system that deals with the dynamics of the blood flow. Various functions are associated with the circulatory system that make it possible for the heart to circulate the blood through the system. Continuous oxygen supply is necessary for the tissues in body to provide healthy and improved quality of life with the help of adequate blood circulation, which is monitored by hemodynamics. Monitoring hemodynamic function in ICUs is critically important for survival of surgical patients and a stable cardiovascular system.
Hemodynamic forces to be monitored are blood pressure and cardiac output. Monitoring conditions differ for intensive care unit patients and patients in emergency care. Basic components required for hemodynamic monitoring are catheter, pressure transducers, pressure monitors, and IV fluid. Hemodynamic monitoring system has become an epicenter of care for critically ill patients in ICUs.
Hemodynamic monitoring systems are used to identify cardiac inadequacy to perform or to understand the effects of the treatment. Major role of hemodynamic monitoring is to guide the cardiovascular therapies facilitating the stability and faster recovery of the patient.
Advanced methods differentiated upon their invasiveness degree or continuous measurement facility are in use such as thoracic electrical impedance, pulse contour analysis, and ultrasound. Finger cuff technology can be used noninvasively for blood pressure monitoring and cardiac output can be measured using pulse contour method.
Ask For Table Of [email protected]
Vast Hemodynamic Monitoring Systems applications and reliability in complex surgeries is expected to boost the growth of the market
Hemodynamic dysfunction is the major cause behind most of the cardiovascular disorders, which makes monitoring hemodynamic function in patients critically important. The two main hemodynamic disorders are congestive heart failure and hypertension.
According to World Health Organization (WHO), 17.5 million people die each year from CVDs. Low-income and middle-income economies account for more than 75% of CVD deaths. Furthermore heart attacks and strokes are responsible for 80% of all CVD deaths.
According to Center for Disease Control and Prevention (CDC), 2015, around 28.4 million people were diagnosed with cardiovascular diseases in the U.S. alone accounting for around 11.7% of the population and are expected to increase, owing to sedentary lifestyle, smoking, and alcohol consumption.
According to the Urgent Care Association of America (UCAOA), 2014, there were approximately 9,000 urgent care centers in operation getting 160 million visits annually. Urgent care industry is set to grow drastically by 2019, owing to rise in number to almost 15000 in turn increasing the demand for hemodynamic systems. Factors like increasing aging population with a higher risk of developing chronic diseases, technological advances, increasing prevalence of chronic diseases mainly CVDs are expected to drive the growth of hemodynamic monitoring systems throughout the forecast period.
Get Customization Report:
Regional growth accelerators of the hemodynamic monitoring systems market
Regional segmentation of the hemodynamic monitoring systems market by Coherent Market Insights comprises North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America region is expected to dominate the market due to highest healthcare spending, maximum patient base, state of the art facilities, and professional expertise. Asia Pacific region is expected to show highest growth rate due to increase in demand for noninvasive hemodynamic systems and presence of maximum number of diabetic population. According to American Diabetic Association, around 60% of the world’s diabetic population lives in Asia as diabetes and cardiac diseases are related to each other. In 2014, around 60 million people in India were diabetic making it diabetes capital of the world. The prevalence of diabetes in India and China is 8.6% and 9.6% respectively.
Key players operating in the hemodynamic monitoring systems market include Pulsion Medical Systems SE, Edwards Lifesciences Corporation, and LiDCO Group plc. Deltex Medical Group Plc., Cheetah Medical Inc., ICU Medical, Inc., Hemo Sapiens, In., Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical, Inc. In 2015, Edwards Lifesciences (NYSE:EW) and Becton Dickinson (NYSE:BDX) subsidiary CareFusion inked an interoperability pact for their respective hemodynamic monitoring and IV fluid administration offerings.